Primary study · included by 1 review
Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
Li 2020 · Li Yongchao, Wu Tinghui, Gong Shujuan, et al. · Frontiers in oncology · 2020
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Overall survival High CXCL10 vs Low CXCL10 · Overall survival | HR 0.79 [0.43, 1.47] | 6 studies | GRADE not reported |
1 including review in total.